1'-Acetyl-[1,4'-bipiperidine]-4-carboxylic acid, 95.0%, 1g

2-(4-Bromophenyl)thiazole, 95.0%, 1g

3-Fluoro-N-isopropylaniline, 95.0%, 10g

(S)-4-Methoxy-3-methyl-4-oxobutanoic acid, 97%, 250mg

5-benzyl-4-cyclohexyl-4H-1,2,4-triazole-3-thiol, 5g

1-Methyl-4-(prop-2-yn-1-yl)piperazine, 98%, 5g

4,6-Dibromodibenzo[b,d]furan, 95.0%, 100g

2-Phenoxyethanol, min 99%, for synthesis, 250 ml, glass packaging

(6aR,6bS,8aS,8bS,9aR,10aS,10bR)-8b-acetyl-6a,8a-dimethyl-5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4(2H)-one, 95.0%, 5g

cis-Epoxysuccinic acid, 97.0%, 250mg

Ethyl 3-((1,3-dioxolan-2-yl)methoxy)benzoate, 97%, 250mg

Sodium 2-(2-aminophenyl)-2-oxoacetate, 95.0%, 5g

4-Bromobenzo[c][1,2,5]oxadiazole, 97%, 1g